Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Statins in primary prevention: impact on mortality. A meta-analysis study
Publication

Publications

Statins in primary prevention: impact on mortality. A meta-analysis study

Title
Statins in primary prevention: impact on mortality. A meta-analysis study
Type
Another Publication in an International Scientific Journal
Year
2017
Authors
José Pedro Nunes
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 65
Pages: 531-538
ISSN: 0026-4725
Other information
Authenticus ID: P-00M-ZEA
Abstract (EN): Introduction: An evaluation of the effects of statins on total mortality in the context of primary prevention was carried out, by means of the analysis of data taken from major clinical trials published in the literature. EVIDENCE ACQUISITION: Published systematic reviews were used to identify relevant clinical trials, and data from the third Heart Outcomes Prevention Evaluation study were also used. Meta-analysis was carried out using overall mortality data. EVIDENCE SYNTHESIS: A total of nine clinical trials were selected for further study, and in each of them patients had defined cardiovascular risk factors. Meta-analysis of the overall mortality results of the nine trials showed a significant reduction associated to statin therapy (odds ratio 0.886, 95% confidence limits 0.816-0.963), when compared to the control situation. At least one trial showed a numerical reduction of overall mortality with pravastatin, with atorvastatin and with rosuvastatin. Separate meta-analyses were carried out with clinical trials with each of these three drugs, yielding similar effects: pravastatin - odds ratio 0.852, 95% confidence limits 0.688-1.054; atorvastatin - odds ratio 0.853, 95% confidence limits 0.726-1.002; rosuvastatin - odds ratio 0.870, 95% confidence limits 0.749-1.010. CONCLUSIONS: Statins used in primary prevention lead to a significant decrease in overall mortality. The effects of statins in primary prevention are limited to patients with defined cardiovascular risk factors.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Social media use by cardiovascular healthcare professionals: Exploring a challenging and ever evolving frontier (2023)
Another Publication in a National Scientific Journal
Vilela, EM; José Pedro Nunes
Vascular calcification in patients with preserved renal function (2005)
Another Publication in an International Scientific Journal
José Pedro Nunes
Troponin I elevation after pericardiocentesis for cardiac tamponade: a role for myocardial strain? (2001)
Another Publication in an International Scientific Journal
José Pedro Nunes; Magalhaes, D; Dias, P; Faria, DB
To the editor (2017)
Another Publication in an International Scientific Journal
José Pedro Nunes
Takotsubo cardiomyopathy and chronic obstructive pulmonary disease - Reply (2014)
Another Publication in an International Scientific Journal
Melao, F; José Pedro Nunes

See all (141)

Of the same journal

The role of adipose tissue in coronary atherosclerosis (2010)
Another Publication in an International Scientific Journal
ferreira, j; monteiro, r; canedo, a; vaz, ag; azevedo, i
Cardiovascular effects of heat-not-burn and electronic-vaping-cigarettes in smokers (2020)
Another Publication in an International Scientific Journal
Marco Lombardi; José Pedro Nunes; Salvatore Carbone
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-06 at 22:58:11 | Privacy Policy | Personal Data Protection Policy | Whistleblowing